These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 23471664)
1. Microtubule affinity-regulating kinase 4: structure, function, and regulation. Naz F; Anjum F; Islam A; Ahmad F; Hassan MI Cell Biochem Biophys; 2013 Nov; 67(2):485-99. PubMed ID: 23471664 [TBL] [Abstract][Full Text] [Related]
2. Suggestive evidence on the involvement of polypyrimidine-tract binding protein in regulating alternative splicing of MAP/microtubule affinity-regulating kinase 4 in glioma. Fontana L; Rovina D; Novielli C; Maffioli E; Tedeschi G; Magnani I; Larizza L Cancer Lett; 2015 Apr; 359(1):87-96. PubMed ID: 25578778 [TBL] [Abstract][Full Text] [Related]
3. Distinct expression pattern of microtubule-associated protein/microtubule affinity-regulating kinase 4 in differentiated neurons. Moroni RF; De Biasi S; Colapietro P; Larizza L; Beghini A Neuroscience; 2006 Nov; 143(1):83-94. PubMed ID: 16973293 [TBL] [Abstract][Full Text] [Related]
4. Microtubule-associated protein/microtubule affinity-regulating kinase 4 (MARK4) plays a role in cell cycle progression and cytoskeletal dynamics. Rovina D; Fontana L; Monti L; Novielli C; Panini N; Sirchia SM; Erba E; Magnani I; Larizza L Eur J Cell Biol; 2014; 93(8-9):355-65. PubMed ID: 25123532 [TBL] [Abstract][Full Text] [Related]
5. Differential signature of the centrosomal MARK4 isoforms in glioma. Magnani I; Novielli C; Fontana L; Tabano S; Rovina D; Moroni RF; Bauer D; Mazzoleni S; Colombo EA; Tedeschi G; Monti L; Porta G; Bosari S; Frassoni C; Galli R; Bello L; Larizza L Anal Cell Pathol (Amst); 2011; 34(6):319-38. PubMed ID: 22156016 [TBL] [Abstract][Full Text] [Related]
6. Atypical PKC phosphorylates microtubule affinity-regulating kinase 4 in vitro. Naz F; Islam A; Ahmad F; Hassan MI Mol Cell Biochem; 2015 Dec; 410(1-2):223-8. PubMed ID: 26346160 [TBL] [Abstract][Full Text] [Related]
7. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc). Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785 [TBL] [Abstract][Full Text] [Related]
8. Human microtubule affinity-regulating kinase 4 is stable at extremes of pH. Naz F; Singh P; Islam A; Ahmad F; Imtaiyaz Hassan M J Biomol Struct Dyn; 2016 Jun; 34(6):1241-51. PubMed ID: 26208600 [TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-associated domain of MARK4 provides stability at physiological pH. Naz F; Sami N; Islam A; Ahmad F; Hassan MI Int J Biol Macromol; 2016 Dec; 93(Pt A):1147-1154. PubMed ID: 27677563 [TBL] [Abstract][Full Text] [Related]
10. MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes. Trinczek B; Brajenovic M; Ebneth A; Drewes G J Biol Chem; 2004 Feb; 279(7):5915-23. PubMed ID: 14594945 [TBL] [Abstract][Full Text] [Related]
11. Crystal structure of microtubule affinity-regulating kinase 4 catalytic domain in complex with a pyrazolopyrimidine inhibitor. Sack JS; Gao M; Kiefer SE; Myers JE; Newitt JA; Wu S; Yan C Acta Crystallogr F Struct Biol Commun; 2016 Feb; 72(Pt 2):129-34. PubMed ID: 26841763 [TBL] [Abstract][Full Text] [Related]
12. The neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell lines. Beghini A; Magnani I; Roversi G; Piepoli T; Di Terlizzi S; Moroni RF; Pollo B; Fuhrman Conti AM; Cowell JK; Finocchiaro G; Larizza L Oncogene; 2003 May; 22(17):2581-91. PubMed ID: 12735302 [TBL] [Abstract][Full Text] [Related]
13. Cloning, expression, purification and refolding of microtubule affinity-regulating kinase 4 expressed in Escherichia coli. Naz F; Asad M; Malhotra P; Islam A; Ahmad F; Hassan MI Appl Biochem Biotechnol; 2014 Mar; 172(6):2838-48. PubMed ID: 24446173 [TBL] [Abstract][Full Text] [Related]
14. PKR-inhibitor binds efficiently with human microtubule affinity-regulating kinase 4. Naz F; Shahbaaz M; Khan S; Bisetty K; Islam A; Ahmad F; Hassan MI J Mol Graph Model; 2015 Nov; 62():245-252. PubMed ID: 26519933 [TBL] [Abstract][Full Text] [Related]
15. Designing New Kinase Inhibitor Derivatives as Therapeutics Against Common Complex Diseases: Structural Basis of Microtubule Affinity-Regulating Kinase 4 (MARK4) Inhibition. Naz F; Shahbaaz M; Bisetty K; Islam A; Ahmad F; Hassan MI OMICS; 2015 Nov; 19(11):700-11. PubMed ID: 26565604 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of human microtubule affinity-regulating kinase 4 inhibitors: fluorescence binding studies, enzyme, and cell assays. Naz F; Sami N; Naqvi AT; Islam A; Ahmad F; Imtaiyaz Hassan M J Biomol Struct Dyn; 2017 Nov; 35(14):3194-3203. PubMed ID: 27748164 [TBL] [Abstract][Full Text] [Related]
17. The structural analysis of MARK4 and the exploration of specific inhibitors for the MARK family: a computational approach to obstruct the role of MARK4 in prostate cancer progression. Jenardhanan P; Mannu J; Mathur PP Mol Biosyst; 2014 Jul; 10(7):1845-68. PubMed ID: 24763618 [TBL] [Abstract][Full Text] [Related]
18. Investigation of molecular mechanism of recognition between citral and MARK4: A newer therapeutic approach to attenuate cancer cell progression. Naz F; Khan FI; Mohammad T; Khan P; Manzoor S; Hasan GM; Lobb KA; Luqman S; Islam A; Ahmad F; Hassan MI Int J Biol Macromol; 2018 Feb; 107(Pt B):2580-2589. PubMed ID: 29079437 [TBL] [Abstract][Full Text] [Related]
19. Structure and dynamics of inactive and active MARK4: conformational switching through the activation process. Ahrari S; Mogharrab N; Navapour L J Biomol Struct Dyn; 2020 May; 38(8):2468-2481. PubMed ID: 31411112 [TBL] [Abstract][Full Text] [Related]
20. A novel p21-activated kinase binds the actin and microtubule networks and induces microtubule stabilization. Cau J; Faure S; Comps M; Delsert C; Morin N J Cell Biol; 2001 Dec; 155(6):1029-42. PubMed ID: 11733543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]